nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—Methoxsalen—hematologic cancer	0.0327	0.046	CbGbCtD
Methimazole—CYP1A2—Anagrelide—hematologic cancer	0.028	0.0393	CbGbCtD
Methimazole—CYP2B6—Thiotepa—hematologic cancer	0.0274	0.0385	CbGbCtD
Methimazole—CYP2A6—Ifosfamide—hematologic cancer	0.0239	0.0336	CbGbCtD
Methimazole—CYP2E1—Thalidomide—hematologic cancer	0.0179	0.0252	CbGbCtD
Methimazole—CYP2C9—Bexarotene—hematologic cancer	0.0175	0.0246	CbGbCtD
Methimazole—CYP2A6—Prednisolone—hematologic cancer	0.0159	0.0224	CbGbCtD
Methimazole—CYP2B6—Ifosfamide—hematologic cancer	0.0155	0.0219	CbGbCtD
Methimazole—CYP2E1—Dacarbazine—hematologic cancer	0.0154	0.0217	CbGbCtD
Methimazole—CYP2D6—Lomustine—hematologic cancer	0.0149	0.0209	CbGbCtD
Methimazole—CYP1A2—Carmustine—hematologic cancer	0.0147	0.0207	CbGbCtD
Methimazole—CYP2C9—Idarubicin—hematologic cancer	0.0145	0.0204	CbGbCtD
Methimazole—CYP2B6—Nilotinib—hematologic cancer	0.0135	0.019	CbGbCtD
Methimazole—CYP2D6—Idarubicin—hematologic cancer	0.0132	0.0186	CbGbCtD
Methimazole—CYP2C19—Bortezomib—hematologic cancer	0.0129	0.0181	CbGbCtD
Methimazole—CYP1A2—Methoxsalen—hematologic cancer	0.0125	0.0176	CbGbCtD
Methimazole—CYP2E1—Mitoxantrone—hematologic cancer	0.0119	0.0168	CbGbCtD
Methimazole—CYP1A2—Bortezomib—hematologic cancer	0.0119	0.0167	CbGbCtD
Methimazole—CYP1A2—Daunorubicin—hematologic cancer	0.0114	0.016	CbGbCtD
Methimazole—CYP2D6—Hydroxyurea—hematologic cancer	0.0113	0.0158	CbGbCtD
Methimazole—CYP2C19—Thalidomide—hematologic cancer	0.0112	0.0158	CbGbCtD
Methimazole—CYP1A2—Alitretinoin—hematologic cancer	0.0111	0.0157	CbGbCtD
Methimazole—CYP2C9—Bortezomib—hematologic cancer	0.0107	0.0151	CbGbCtD
Methimazole—CYP2C19—Teniposide—hematologic cancer	0.0107	0.0151	CbGbCtD
Methimazole—CYP1A2—Thalidomide—hematologic cancer	0.0104	0.0146	CbGbCtD
Methimazole—CYP3A4—Bexarotene—hematologic cancer	0.0102	0.0143	CbGbCtD
Methimazole—CYP2C19—Ifosfamide—hematologic cancer	0.00988	0.0139	CbGbCtD
Methimazole—CYP2D6—Bortezomib—hematologic cancer	0.00979	0.0138	CbGbCtD
Methimazole—CYP3A4—Busulfan—hematologic cancer	0.00944	0.0133	CbGbCtD
Methimazole—CYP3A4—Lomustine—hematologic cancer	0.00944	0.0133	CbGbCtD
Methimazole—CYP2C19—Imatinib—hematologic cancer	0.00944	0.0133	CbGbCtD
Methimazole—CYP2A6—Dexamethasone—hematologic cancer	0.00938	0.0132	CbGbCtD
Methimazole—CYP2C9—Thalidomide—hematologic cancer	0.00933	0.0131	CbGbCtD
Methimazole—CYP2B6—Irinotecan—hematologic cancer	0.00928	0.013	CbGbCtD
Methimazole—CYP1A2—Dacarbazine—hematologic cancer	0.0089	0.0125	CbGbCtD
Methimazole—CYP2C9—Teniposide—hematologic cancer	0.0089	0.0125	CbGbCtD
Methimazole—CYP1A2—Imatinib—hematologic cancer	0.00871	0.0122	CbGbCtD
Methimazole—CYP3A4—Thiotepa—hematologic cancer	0.00842	0.0118	CbGbCtD
Methimazole—CYP2C9—Ifosfamide—hematologic cancer	0.00821	0.0116	CbGbCtD
Methimazole—CYP2C9—Imatinib—hematologic cancer	0.00785	0.011	CbGbCtD
Methimazole—CYP2B6—Cisplatin—hematologic cancer	0.00756	0.0106	CbGbCtD
Methimazole—CYP2E1—Etoposide—hematologic cancer	0.00753	0.0106	CbGbCtD
Methimazole—CYP2D6—Imatinib—hematologic cancer	0.00717	0.0101	CbGbCtD
Methimazole—CYP2C9—Nilotinib—hematologic cancer	0.00713	0.01	CbGbCtD
Methimazole—CYP1A2—Dasatinib—hematologic cancer	0.00699	0.00984	CbGbCtD
Methimazole—CYP3A4—Methoxsalen—hematologic cancer	0.00655	0.00921	CbGbCtD
Methimazole—CYP2D6—Nilotinib—hematologic cancer	0.00652	0.00917	CbGbCtD
Methimazole—CYP2D6—Vinorelbine—hematologic cancer	0.00646	0.00909	CbGbCtD
Methimazole—CYP3A4—Bortezomib—hematologic cancer	0.00623	0.00876	CbGbCtD
Methimazole—CYP2C19—Prednisone—hematologic cancer	0.00622	0.00874	CbGbCtD
Methimazole—CYP2E1—Dexamethasone—hematologic cancer	0.00619	0.00871	CbGbCtD
Methimazole—CYP2B6—Dexamethasone—hematologic cancer	0.00611	0.00859	CbGbCtD
Methimazole—CYP3A4—Daunorubicin—hematologic cancer	0.00596	0.00838	CbGbCtD
Methimazole—CYP3A4—Cytarabine—hematologic cancer	0.00525	0.00739	CbGbCtD
Methimazole—CYP3A4—Teniposide—hematologic cancer	0.00517	0.00728	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—hematologic cancer	0.00507	0.00713	CbGbCtD
Methimazole—CYP3A4—Ifosfamide—hematologic cancer	0.00478	0.00672	CbGbCtD
Methimazole—CYP3A4—Imatinib—hematologic cancer	0.00456	0.00642	CbGbCtD
Methimazole—CYP1A2—Etoposide—hematologic cancer	0.00436	0.00613	CbGbCtD
Methimazole—CYP3A4—Ruxolitinib—hematologic cancer	0.0043	0.00604	CbGbCtD
Methimazole—CYP3A4—Nilotinib—hematologic cancer	0.00415	0.00583	CbGbCtD
Methimazole—CYP3A4—Vinorelbine—hematologic cancer	0.00411	0.00578	CbGbCtD
Methimazole—CYP2C9—Cisplatin—hematologic cancer	0.00399	0.00562	CbGbCtD
Methimazole—CYP2D6—Vinblastine—hematologic cancer	0.00398	0.0056	CbGbCtD
Methimazole—CYP2C19—Dexamethasone—hematologic cancer	0.00388	0.00546	CbGbCtD
Methimazole—CYP3A4—Triamcinolone—hematologic cancer	0.00376	0.00529	CbGbCtD
Methimazole—CYP3A4—Dasatinib—hematologic cancer	0.00366	0.00515	CbGbCtD
Methimazole—CYP3A4—Mitoxantrone—hematologic cancer	0.00362	0.00509	CbGbCtD
Methimazole—CYP2C9—Dexamethasone—hematologic cancer	0.00323	0.00454	CbGbCtD
Methimazole—CYP3A4—Betamethasone—hematologic cancer	0.00323	0.00454	CbGbCtD
Methimazole—CYP3A4—Prednisolone—hematologic cancer	0.00318	0.00448	CbGbCtD
Methimazole—TPO—hematopoietic system—hematologic cancer	0.00303	0.22	CbGeAlD
Methimazole—CYP3A4—Prednisone—hematologic cancer	0.00301	0.00423	CbGbCtD
Methimazole—CYP2D6—Dexamethasone—hematologic cancer	0.00295	0.00415	CbGbCtD
Methimazole—CYP3A4—Irinotecan—hematologic cancer	0.00285	0.00401	CbGbCtD
Methimazole—CYP3A4—Vinblastine—hematologic cancer	0.00253	0.00356	CbGbCtD
Methimazole—CYP3A4—Vincristine—hematologic cancer	0.00249	0.0035	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—hematologic cancer	0.00245	0.00344	CbGbCtD
Methimazole—CYP3A4—Etoposide—hematologic cancer	0.00228	0.00321	CbGbCtD
Methimazole—CYP3A4—Dexamethasone—hematologic cancer	0.00188	0.00264	CbGbCtD
Methimazole—TPO—testis—hematologic cancer	0.00166	0.121	CbGeAlD
Methimazole—CYP3A4—Doxorubicin—hematologic cancer	0.00156	0.00219	CbGbCtD
Methimazole—CYP2C19—hematopoietic system—hematologic cancer	0.000707	0.0515	CbGeAlD
Methimazole—CYP2A6—lung—hematologic cancer	0.000639	0.0465	CbGeAlD
Methimazole—CYP1A2—hematopoietic system—hematologic cancer	0.000578	0.0421	CbGeAlD
Methimazole—CYP2B6—hematopoietic system—hematologic cancer	0.000554	0.0404	CbGeAlD
Methimazole—CYP2C9—hematopoietic system—hematologic cancer	0.000548	0.04	CbGeAlD
Methimazole—CYP2E1—hematopoietic system—hematologic cancer	0.00052	0.0379	CbGeAlD
Methimazole—CYP2C19—blood—hematologic cancer	0.000469	0.0341	CbGeAlD
Methimazole—CYP2B6—gonad—hematologic cancer	0.000421	0.0307	CbGeAlD
Methimazole—CYP3A4—hematopoietic system—hematologic cancer	0.000418	0.0305	CbGeAlD
Methimazole—CYP2D6—hematopoietic system—hematologic cancer	0.000412	0.03	CbGeAlD
Methimazole—CYP1A2—blood—hematologic cancer	0.000383	0.0279	CbGeAlD
Methimazole—CYP2B6—blood—hematologic cancer	0.000367	0.0267	CbGeAlD
Methimazole—CYP2C9—blood—hematologic cancer	0.000363	0.0265	CbGeAlD
Methimazole—CYP2E1—blood—hematologic cancer	0.000344	0.0251	CbGeAlD
Methimazole—CYP1A2—lung—hematologic cancer	0.000336	0.0244	CbGeAlD
Methimazole—CYP2B6—lung—hematologic cancer	0.000322	0.0234	CbGeAlD
Methimazole—CYP2B6—testis—hematologic cancer	0.000303	0.0221	CbGeAlD
Methimazole—CYP2E1—lung—hematologic cancer	0.000302	0.022	CbGeAlD
Methimazole—CYP2E1—testis—hematologic cancer	0.000285	0.0208	CbGeAlD
Methimazole—CYP3A4—blood—hematologic cancer	0.000277	0.0202	CbGeAlD
Methimazole—CYP2D6—blood—hematologic cancer	0.000273	0.0199	CbGeAlD
Methimazole—CYP2D6—testis—hematologic cancer	0.000226	0.0164	CbGeAlD
Methimazole—Dyspepsia—Irinotecan—hematologic cancer	0.000125	0.000673	CcSEcCtD
Methimazole—Dyspepsia—Mitoxantrone—hematologic cancer	0.000125	0.000673	CcSEcCtD
Methimazole—Pruritus—Bortezomib—hematologic cancer	0.000125	0.000672	CcSEcCtD
Methimazole—Rash—Melphalan—hematologic cancer	0.000124	0.000669	CcSEcCtD
Methimazole—Paraesthesia—Gemcitabine—hematologic cancer	0.000124	0.000669	CcSEcCtD
Methimazole—Dermatitis—Melphalan—hematologic cancer	0.000124	0.000669	CcSEcCtD
Methimazole—Pruritus—Bleomycin—hematologic cancer	0.000124	0.000667	CcSEcCtD
Methimazole—Nausea—Vinblastine—hematologic cancer	0.000123	0.000663	CcSEcCtD
Methimazole—Somnolence—Gemcitabine—hematologic cancer	0.000123	0.000662	CcSEcCtD
Methimazole—Vomiting—Lenalidomide—hematologic cancer	0.000122	0.000656	CcSEcCtD
Methimazole—Pruritus—Vinorelbine—hematologic cancer	0.000122	0.000656	CcSEcCtD
Methimazole—Alopecia—Dexamethasone—hematologic cancer	0.000121	0.000651	CcSEcCtD
Methimazole—Alopecia—Betamethasone—hematologic cancer	0.000121	0.000651	CcSEcCtD
Methimazole—Rash—Lenalidomide—hematologic cancer	0.000121	0.000651	CcSEcCtD
Methimazole—Body temperature increased—Carmustine—hematologic cancer	0.000121	0.00065	CcSEcCtD
Methimazole—Dermatitis—Lenalidomide—hematologic cancer	0.00012	0.00065	CcSEcCtD
Methimazole—Urticaria—Alitretinoin—hematologic cancer	0.00012	0.000647	CcSEcCtD
Methimazole—Vomiting—Hydroxyurea—hematologic cancer	0.00012	0.000647	CcSEcCtD
Methimazole—Headache—Lenalidomide—hematologic cancer	0.00012	0.000647	CcSEcCtD
Methimazole—Body temperature increased—Alitretinoin—hematologic cancer	0.000119	0.000644	CcSEcCtD
Methimazole—Rash—Hydroxyurea—hematologic cancer	0.000119	0.000642	CcSEcCtD
Methimazole—Dermatitis—Hydroxyurea—hematologic cancer	0.000119	0.000641	CcSEcCtD
Methimazole—Urticaria—Ifosfamide—hematologic cancer	0.000119	0.00064	CcSEcCtD
Methimazole—Headache—Hydroxyurea—hematologic cancer	0.000118	0.000637	CcSEcCtD
Methimazole—Body temperature increased—Ifosfamide—hematologic cancer	0.000118	0.000637	CcSEcCtD
Methimazole—Vertigo—Triamcinolone—hematologic cancer	0.000118	0.000635	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000117	0.000633	CcSEcCtD
Methimazole—Nausea—Melphalan—hematologic cancer	0.000117	0.00063	CcSEcCtD
Methimazole—Oedema—Prednisolone—hematologic cancer	0.000116	0.000627	CcSEcCtD
Methimazole—Pruritus—Thiotepa—hematologic cancer	0.000116	0.000627	CcSEcCtD
Methimazole—Paraesthesia—Cisplatin—hematologic cancer	0.000116	0.000623	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—hematologic cancer	0.000115	0.000623	CcSEcCtD
Methimazole—Body temperature increased—Vincristine—hematologic cancer	0.000115	0.000621	CcSEcCtD
Methimazole—Nausea—Lenalidomide—hematologic cancer	0.000114	0.000613	CcSEcCtD
Methimazole—Urticaria—Mitoxantrone—hematologic cancer	0.000113	0.000608	CcSEcCtD
Methimazole—Pruritus—Thalidomide—hematologic cancer	0.000112	0.000606	CcSEcCtD
Methimazole—Body temperature increased—Irinotecan—hematologic cancer	0.000112	0.000605	CcSEcCtD
Methimazole—Body temperature increased—Mitoxantrone—hematologic cancer	0.000112	0.000605	CcSEcCtD
Methimazole—Nausea—Hydroxyurea—hematologic cancer	0.000112	0.000604	CcSEcCtD
Methimazole—Vomiting—Bortezomib—hematologic cancer	0.000112	0.000604	CcSEcCtD
Methimazole—Myalgia—Triamcinolone—hematologic cancer	0.000112	0.000602	CcSEcCtD
Methimazole—Vomiting—Bleomycin—hematologic cancer	0.000111	0.000599	CcSEcCtD
Methimazole—Rash—Bortezomib—hematologic cancer	0.000111	0.000599	CcSEcCtD
Methimazole—Dermatitis—Bortezomib—hematologic cancer	0.000111	0.000598	CcSEcCtD
Methimazole—Drowsiness—Methotrexate—hematologic cancer	0.000111	0.000597	CcSEcCtD
Methimazole—Headache—Bortezomib—hematologic cancer	0.00011	0.000595	CcSEcCtD
Methimazole—Rash—Bleomycin—hematologic cancer	0.00011	0.000594	CcSEcCtD
Methimazole—Dermatitis—Bleomycin—hematologic cancer	0.00011	0.000594	CcSEcCtD
Methimazole—Vomiting—Vinorelbine—hematologic cancer	0.000109	0.00059	CcSEcCtD
Methimazole—Body temperature increased—Gemcitabine—hematologic cancer	0.000109	0.000589	CcSEcCtD
Methimazole—Rash—Vinorelbine—hematologic cancer	0.000108	0.000585	CcSEcCtD
Methimazole—Dermatitis—Vinorelbine—hematologic cancer	0.000108	0.000584	CcSEcCtD
Methimazole—Headache—Vinorelbine—hematologic cancer	0.000108	0.000581	CcSEcCtD
Methimazole—Oedema—Triamcinolone—hematologic cancer	0.000107	0.000577	CcSEcCtD
Methimazole—Pruritus—Alitretinoin—hematologic cancer	0.000107	0.000577	CcSEcCtD
Methimazole—Vertigo—Dexamethasone—hematologic cancer	0.000107	0.000576	CcSEcCtD
Methimazole—Vertigo—Betamethasone—hematologic cancer	0.000107	0.000576	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—hematologic cancer	0.000106	0.000571	CcSEcCtD
Methimazole—Pruritus—Ifosfamide—hematologic cancer	0.000106	0.00057	CcSEcCtD
Methimazole—Alopecia—Prednisone—hematologic cancer	0.000105	0.000567	CcSEcCtD
Methimazole—Somnolence—Etoposide—hematologic cancer	0.000105	0.000566	CcSEcCtD
Methimazole—Nausea—Bortezomib—hematologic cancer	0.000105	0.000564	CcSEcCtD
Methimazole—Paraesthesia—Prednisolone—hematologic cancer	0.000104	0.000563	CcSEcCtD
Methimazole—Vomiting—Thiotepa—hematologic cancer	0.000104	0.000563	CcSEcCtD
Methimazole—Nausea—Bleomycin—hematologic cancer	0.000104	0.00056	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—hematologic cancer	0.000104	0.000559	CcSEcCtD
Methimazole—Rash—Thiotepa—hematologic cancer	0.000103	0.000558	CcSEcCtD
Methimazole—Dermatitis—Thiotepa—hematologic cancer	0.000103	0.000558	CcSEcCtD
Methimazole—Agranulocytosis—Methotrexate—hematologic cancer	0.000103	0.000558	CcSEcCtD
Methimazole—Headache—Thiotepa—hematologic cancer	0.000103	0.000555	CcSEcCtD
Methimazole—Nausea—Vinorelbine—hematologic cancer	0.000102	0.000551	CcSEcCtD
Methimazole—Body temperature increased—Cisplatin—hematologic cancer	0.000102	0.000549	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000102	0.000548	CcSEcCtD
Methimazole—Myalgia—Dexamethasone—hematologic cancer	0.000101	0.000546	CcSEcCtD
Methimazole—Myalgia—Betamethasone—hematologic cancer	0.000101	0.000546	CcSEcCtD
Methimazole—Jaundice—Epirubicin—hematologic cancer	0.000101	0.000545	CcSEcCtD
Methimazole—Vomiting—Thalidomide—hematologic cancer	0.000101	0.000545	CcSEcCtD
Methimazole—Rash—Thalidomide—hematologic cancer	0.0001	0.00054	CcSEcCtD
Methimazole—Dermatitis—Thalidomide—hematologic cancer	0.0001	0.00054	CcSEcCtD
Methimazole—Headache—Thalidomide—hematologic cancer	9.94e-05	0.000537	CcSEcCtD
Methimazole—Hepatitis—Methotrexate—hematologic cancer	9.94e-05	0.000536	CcSEcCtD
Methimazole—Pruritus—Gemcitabine—hematologic cancer	9.77e-05	0.000527	CcSEcCtD
Methimazole—Nausea—Thiotepa—hematologic cancer	9.75e-05	0.000526	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	9.74e-05	0.000526	CcSEcCtD
Methimazole—Oedema—Dexamethasone—hematologic cancer	9.7e-05	0.000524	CcSEcCtD
Methimazole—Oedema—Betamethasone—hematologic cancer	9.7e-05	0.000524	CcSEcCtD
Methimazole—Vomiting—Carmustine—hematologic cancer	9.69e-05	0.000523	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—hematologic cancer	9.67e-05	0.000522	CcSEcCtD
Methimazole—Rash—Carmustine—hematologic cancer	9.61e-05	0.000519	CcSEcCtD
Methimazole—Dermatitis—Carmustine—hematologic cancer	9.6e-05	0.000518	CcSEcCtD
Methimazole—Vomiting—Alitretinoin—hematologic cancer	9.6e-05	0.000518	CcSEcCtD
Methimazole—Paraesthesia—Triamcinolone—hematologic cancer	9.6e-05	0.000518	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—hematologic cancer	9.59e-05	0.000517	CcSEcCtD
Methimazole—Headache—Carmustine—hematologic cancer	9.55e-05	0.000515	CcSEcCtD
Methimazole—Rash—Alitretinoin—hematologic cancer	9.52e-05	0.000514	CcSEcCtD
Methimazole—Dermatitis—Alitretinoin—hematologic cancer	9.51e-05	0.000513	CcSEcCtD
Methimazole—Thrombocytopenia—Dexamethasone—hematologic cancer	9.5e-05	0.000513	CcSEcCtD
Methimazole—Thrombocytopenia—Betamethasone—hematologic cancer	9.5e-05	0.000513	CcSEcCtD
Methimazole—Vomiting—Ifosfamide—hematologic cancer	9.49e-05	0.000512	CcSEcCtD
Methimazole—Headache—Alitretinoin—hematologic cancer	9.46e-05	0.000511	CcSEcCtD
Methimazole—Nausea—Thalidomide—hematologic cancer	9.43e-05	0.000509	CcSEcCtD
Methimazole—Dyspepsia—Triamcinolone—hematologic cancer	9.41e-05	0.000508	CcSEcCtD
Methimazole—Rash—Ifosfamide—hematologic cancer	9.41e-05	0.000508	CcSEcCtD
Methimazole—Dermatitis—Ifosfamide—hematologic cancer	9.4e-05	0.000507	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—hematologic cancer	9.4e-05	0.000507	CcSEcCtD
Methimazole—Urticaria—Etoposide—hematologic cancer	9.37e-05	0.000505	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—hematologic cancer	9.34e-05	0.000504	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—hematologic cancer	9.32e-05	0.000503	CcSEcCtD
Methimazole—Vertigo—Prednisone—hematologic cancer	9.3e-05	0.000502	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—hematologic cancer	9.3e-05	0.000502	CcSEcCtD
Methimazole—Vomiting—Vincristine—hematologic cancer	9.25e-05	0.000499	CcSEcCtD
Methimazole—Urticaria—Prednisolone—hematologic cancer	9.24e-05	0.000498	CcSEcCtD
Methimazole—Rash—Vincristine—hematologic cancer	9.18e-05	0.000495	CcSEcCtD
Methimazole—Dermatitis—Vincristine—hematologic cancer	9.17e-05	0.000495	CcSEcCtD
Methimazole—Headache—Vincristine—hematologic cancer	9.12e-05	0.000492	CcSEcCtD
Methimazole—Nausea—Carmustine—hematologic cancer	9.06e-05	0.000489	CcSEcCtD
Methimazole—Vomiting—Irinotecan—hematologic cancer	9.01e-05	0.000486	CcSEcCtD
Methimazole—Vomiting—Mitoxantrone—hematologic cancer	9.01e-05	0.000486	CcSEcCtD
Methimazole—Nausea—Alitretinoin—hematologic cancer	8.97e-05	0.000484	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—hematologic cancer	8.95e-05	0.000483	CcSEcCtD
Methimazole—Rash—Mitoxantrone—hematologic cancer	8.94e-05	0.000482	CcSEcCtD
Methimazole—Rash—Irinotecan—hematologic cancer	8.94e-05	0.000482	CcSEcCtD
Methimazole—Dermatitis—Mitoxantrone—hematologic cancer	8.93e-05	0.000482	CcSEcCtD
Methimazole—Dermatitis—Irinotecan—hematologic cancer	8.93e-05	0.000482	CcSEcCtD
Methimazole—Headache—Mitoxantrone—hematologic cancer	8.88e-05	0.000479	CcSEcCtD
Methimazole—Headache—Irinotecan—hematologic cancer	8.88e-05	0.000479	CcSEcCtD
Methimazole—Nausea—Ifosfamide—hematologic cancer	8.87e-05	0.000478	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Betamethasone—hematologic cancer	8.84e-05	0.000477	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	8.84e-05	0.000477	CcSEcCtD
Methimazole—Arthralgia—Prednisone—hematologic cancer	8.81e-05	0.000476	CcSEcCtD
Methimazole—Myalgia—Prednisone—hematologic cancer	8.81e-05	0.000476	CcSEcCtD
Methimazole—Alopecia—Methotrexate—hematologic cancer	8.78e-05	0.000474	CcSEcCtD
Methimazole—Vomiting—Gemcitabine—hematologic cancer	8.78e-05	0.000474	CcSEcCtD
Methimazole—Paraesthesia—Dexamethasone—hematologic cancer	8.71e-05	0.00047	CcSEcCtD
Methimazole—Paraesthesia—Betamethasone—hematologic cancer	8.71e-05	0.00047	CcSEcCtD
Methimazole—Rash—Gemcitabine—hematologic cancer	8.7e-05	0.00047	CcSEcCtD
Methimazole—Dermatitis—Gemcitabine—hematologic cancer	8.7e-05	0.000469	CcSEcCtD
Methimazole—Headache—Gemcitabine—hematologic cancer	8.65e-05	0.000467	CcSEcCtD
Methimazole—Nausea—Vincristine—hematologic cancer	8.64e-05	0.000466	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—hematologic cancer	8.61e-05	0.000464	CcSEcCtD
Methimazole—Dyspepsia—Dexamethasone—hematologic cancer	8.54e-05	0.000461	CcSEcCtD
Methimazole—Dyspepsia—Betamethasone—hematologic cancer	8.54e-05	0.000461	CcSEcCtD
Methimazole—Urticaria—Triamcinolone—hematologic cancer	8.49e-05	0.000458	CcSEcCtD
Methimazole—Body temperature increased—Triamcinolone—hematologic cancer	8.45e-05	0.000456	CcSEcCtD
Methimazole—Oedema—Prednisone—hematologic cancer	8.45e-05	0.000456	CcSEcCtD
Methimazole—Nausea—Mitoxantrone—hematologic cancer	8.42e-05	0.000454	CcSEcCtD
Methimazole—Nausea—Irinotecan—hematologic cancer	8.42e-05	0.000454	CcSEcCtD
Methimazole—Pruritus—Etoposide—hematologic cancer	8.34e-05	0.00045	CcSEcCtD
Methimazole—Alopecia—Epirubicin—hematologic cancer	8.22e-05	0.000444	CcSEcCtD
Methimazole—Nausea—Gemcitabine—hematologic cancer	8.2e-05	0.000442	CcSEcCtD
Methimazole—Vomiting—Cisplatin—hematologic cancer	8.18e-05	0.000441	CcSEcCtD
Methimazole—Rash—Cisplatin—hematologic cancer	8.11e-05	0.000438	CcSEcCtD
Methimazole—Dermatitis—Cisplatin—hematologic cancer	8.11e-05	0.000437	CcSEcCtD
Methimazole—Vertigo—Methotrexate—hematologic cancer	7.77e-05	0.000419	CcSEcCtD
Methimazole—Leukopenia—Methotrexate—hematologic cancer	7.74e-05	0.000418	CcSEcCtD
Methimazole—Urticaria—Dexamethasone—hematologic cancer	7.71e-05	0.000416	CcSEcCtD
Methimazole—Urticaria—Betamethasone—hematologic cancer	7.71e-05	0.000416	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.7e-05	0.000415	CcSEcCtD
Methimazole—Body temperature increased—Betamethasone—hematologic cancer	7.67e-05	0.000414	CcSEcCtD
Methimazole—Body temperature increased—Dexamethasone—hematologic cancer	7.67e-05	0.000414	CcSEcCtD
Methimazole—Nausea—Cisplatin—hematologic cancer	7.64e-05	0.000412	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—hematologic cancer	7.6e-05	0.00041	CcSEcCtD
Methimazole—Paraesthesia—Prednisone—hematologic cancer	7.59e-05	0.000409	CcSEcCtD
Methimazole—Pruritus—Triamcinolone—hematologic cancer	7.56e-05	0.000408	CcSEcCtD
Methimazole—Vomiting—Etoposide—hematologic cancer	7.5e-05	0.000404	CcSEcCtD
Methimazole—Dyspepsia—Prednisone—hematologic cancer	7.44e-05	0.000401	CcSEcCtD
Methimazole—Rash—Etoposide—hematologic cancer	7.43e-05	0.000401	CcSEcCtD
Methimazole—Dermatitis—Etoposide—hematologic cancer	7.43e-05	0.000401	CcSEcCtD
Methimazole—Headache—Etoposide—hematologic cancer	7.39e-05	0.000399	CcSEcCtD
Methimazole—Myalgia—Methotrexate—hematologic cancer	7.37e-05	0.000397	CcSEcCtD
Methimazole—Arthralgia—Methotrexate—hematologic cancer	7.37e-05	0.000397	CcSEcCtD
Methimazole—Rash—Prednisolone—hematologic cancer	7.33e-05	0.000396	CcSEcCtD
Methimazole—Dermatitis—Prednisolone—hematologic cancer	7.32e-05	0.000395	CcSEcCtD
Methimazole—Headache—Prednisolone—hematologic cancer	7.28e-05	0.000393	CcSEcCtD
Methimazole—Vertigo—Epirubicin—hematologic cancer	7.27e-05	0.000393	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—hematologic cancer	7.25e-05	0.000391	CcSEcCtD
Methimazole—Nausea—Etoposide—hematologic cancer	7e-05	0.000378	CcSEcCtD
Methimazole—Thrombocytopenia—Methotrexate—hematologic cancer	6.91e-05	0.000373	CcSEcCtD
Methimazole—Nausea—Prednisolone—hematologic cancer	6.91e-05	0.000373	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—hematologic cancer	6.89e-05	0.000372	CcSEcCtD
Methimazole—Myalgia—Epirubicin—hematologic cancer	6.89e-05	0.000372	CcSEcCtD
Methimazole—Pruritus—Betamethasone—hematologic cancer	6.86e-05	0.00037	CcSEcCtD
Methimazole—Pruritus—Dexamethasone—hematologic cancer	6.86e-05	0.00037	CcSEcCtD
Methimazole—Vomiting—Triamcinolone—hematologic cancer	6.8e-05	0.000367	CcSEcCtD
Methimazole—Rash—Triamcinolone—hematologic cancer	6.74e-05	0.000364	CcSEcCtD
Methimazole—Dermatitis—Triamcinolone—hematologic cancer	6.74e-05	0.000363	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—hematologic cancer	6.73e-05	0.000363	CcSEcCtD
Methimazole—Urticaria—Prednisone—hematologic cancer	6.71e-05	0.000362	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—hematologic cancer	6.71e-05	0.000362	CcSEcCtD
Methimazole—Headache—Triamcinolone—hematologic cancer	6.7e-05	0.000361	CcSEcCtD
Methimazole—Body temperature increased—Prednisone—hematologic cancer	6.68e-05	0.00036	CcSEcCtD
Methimazole—Oedema—Epirubicin—hematologic cancer	6.61e-05	0.000357	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—hematologic cancer	6.47e-05	0.000349	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.43e-05	0.000347	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—hematologic cancer	6.38e-05	0.000344	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—hematologic cancer	6.38e-05	0.000344	CcSEcCtD
Methimazole—Nausea—Triamcinolone—hematologic cancer	6.35e-05	0.000343	CcSEcCtD
Methimazole—Paraesthesia—Methotrexate—hematologic cancer	6.34e-05	0.000342	CcSEcCtD
Methimazole—Somnolence—Methotrexate—hematologic cancer	6.28e-05	0.000339	CcSEcCtD
Methimazole—Dyspepsia—Methotrexate—hematologic cancer	6.22e-05	0.000335	CcSEcCtD
Methimazole—Vomiting—Dexamethasone—hematologic cancer	6.17e-05	0.000333	CcSEcCtD
Methimazole—Vomiting—Betamethasone—hematologic cancer	6.17e-05	0.000333	CcSEcCtD
Methimazole—Rash—Betamethasone—hematologic cancer	6.12e-05	0.00033	CcSEcCtD
Methimazole—Rash—Dexamethasone—hematologic cancer	6.12e-05	0.00033	CcSEcCtD
Methimazole—Oedema—Doxorubicin—hematologic cancer	6.11e-05	0.00033	CcSEcCtD
Methimazole—Dermatitis—Dexamethasone—hematologic cancer	6.11e-05	0.00033	CcSEcCtD
Methimazole—Dermatitis—Betamethasone—hematologic cancer	6.11e-05	0.00033	CcSEcCtD
Methimazole—Headache—Dexamethasone—hematologic cancer	6.08e-05	0.000328	CcSEcCtD
Methimazole—Headache—Betamethasone—hematologic cancer	6.08e-05	0.000328	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.02e-05	0.000325	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—hematologic cancer	5.99e-05	0.000323	CcSEcCtD
Methimazole—Pruritus—Prednisone—hematologic cancer	5.98e-05	0.000323	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—hematologic cancer	5.93e-05	0.00032	CcSEcCtD
Methimazole—Somnolence—Epirubicin—hematologic cancer	5.87e-05	0.000317	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—hematologic cancer	5.82e-05	0.000314	CcSEcCtD
Methimazole—Nausea—Dexamethasone—hematologic cancer	5.76e-05	0.000311	CcSEcCtD
Methimazole—Nausea—Betamethasone—hematologic cancer	5.76e-05	0.000311	CcSEcCtD
Methimazole—Urticaria—Methotrexate—hematologic cancer	5.61e-05	0.000303	CcSEcCtD
Methimazole—Body temperature increased—Methotrexate—hematologic cancer	5.58e-05	0.000301	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.57e-05	0.000301	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—hematologic cancer	5.49e-05	0.000296	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—hematologic cancer	5.44e-05	0.000293	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—hematologic cancer	5.38e-05	0.00029	CcSEcCtD
Methimazole—Vomiting—Prednisone—hematologic cancer	5.37e-05	0.00029	CcSEcCtD
Methimazole—Rash—Prednisone—hematologic cancer	5.33e-05	0.000287	CcSEcCtD
Methimazole—Dermatitis—Prednisone—hematologic cancer	5.32e-05	0.000287	CcSEcCtD
Methimazole—Headache—Prednisone—hematologic cancer	5.29e-05	0.000286	CcSEcCtD
Methimazole—Urticaria—Epirubicin—hematologic cancer	5.25e-05	0.000283	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—hematologic cancer	5.22e-05	0.000282	CcSEcCtD
Methimazole—Nausea—Prednisone—hematologic cancer	5.02e-05	0.000271	CcSEcCtD
Methimazole—Pruritus—Methotrexate—hematologic cancer	5e-05	0.00027	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—hematologic cancer	4.86e-05	0.000262	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—hematologic cancer	4.83e-05	0.000261	CcSEcCtD
Methimazole—Pruritus—Epirubicin—hematologic cancer	4.68e-05	0.000252	CcSEcCtD
Methimazole—Vomiting—Methotrexate—hematologic cancer	4.49e-05	0.000242	CcSEcCtD
Methimazole—Rash—Methotrexate—hematologic cancer	4.45e-05	0.00024	CcSEcCtD
Methimazole—Dermatitis—Methotrexate—hematologic cancer	4.45e-05	0.00024	CcSEcCtD
Methimazole—Headache—Methotrexate—hematologic cancer	4.42e-05	0.000239	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—hematologic cancer	4.33e-05	0.000233	CcSEcCtD
Methimazole—Vomiting—Epirubicin—hematologic cancer	4.2e-05	0.000227	CcSEcCtD
Methimazole—Nausea—Methotrexate—hematologic cancer	4.19e-05	0.000226	CcSEcCtD
Methimazole—Rash—Epirubicin—hematologic cancer	4.17e-05	0.000225	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—hematologic cancer	4.16e-05	0.000225	CcSEcCtD
Methimazole—Headache—Epirubicin—hematologic cancer	4.14e-05	0.000223	CcSEcCtD
Methimazole—Nausea—Epirubicin—hematologic cancer	3.93e-05	0.000212	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—hematologic cancer	3.89e-05	0.00021	CcSEcCtD
Methimazole—Rash—Doxorubicin—hematologic cancer	3.86e-05	0.000208	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—hematologic cancer	3.85e-05	0.000208	CcSEcCtD
Methimazole—Headache—Doxorubicin—hematologic cancer	3.83e-05	0.000207	CcSEcCtD
Methimazole—Nausea—Doxorubicin—hematologic cancer	3.63e-05	0.000196	CcSEcCtD
Methimazole—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.18e-06	7.98e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ACP5—hematologic cancer	7.15e-06	7.95e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CA9—hematologic cancer	7.15e-06	7.95e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.15e-06	7.95e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.15e-06	7.95e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NQO1—hematologic cancer	7.13e-06	7.92e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CD44—hematologic cancer	7.13e-06	7.92e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ABCB1—hematologic cancer	7.12e-06	7.92e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.12e-06	7.91e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.12e-06	7.91e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NUP214—hematologic cancer	7.1e-06	7.9e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.06e-06	7.85e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.03e-06	7.81e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALOX5—hematologic cancer	7e-06	7.78e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MTR—hematologic cancer	6.96e-06	7.73e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.96e-06	7.73e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.94e-06	7.71e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTM1—hematologic cancer	6.91e-06	7.69e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NCOR1—hematologic cancer	6.91e-06	7.69e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYCS—hematologic cancer	6.89e-06	7.66e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	6.84e-06	7.61e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ENO2—hematologic cancer	6.82e-06	7.59e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NUP98—hematologic cancer	6.78e-06	7.53e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYCS—hematologic cancer	6.74e-06	7.5e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—IDH1—hematologic cancer	6.72e-06	7.48e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NUP98—hematologic cancer	6.72e-06	7.47e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	6.7e-06	7.45e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.65e-06	7.39e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.65e-06	7.39e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TXN—hematologic cancer	6.65e-06	7.39e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTT1—hematologic cancer	6.62e-06	7.36e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.58e-06	7.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.58e-06	7.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NUP214—hematologic cancer	6.53e-06	7.26e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.52e-06	7.25e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.52e-06	7.25e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.52e-06	7.24e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.51e-06	7.23e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—FHL2—hematologic cancer	6.49e-06	7.22e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NUP214—hematologic cancer	6.47e-06	7.2e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SDC1—hematologic cancer	6.47e-06	7.19e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.41e-06	7.12e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.4e-06	7.11e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MTR—hematologic cancer	6.4e-06	7.11e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AGRN—hematologic cancer	6.37e-06	7.08e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.34e-06	7.05e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MTR—hematologic cancer	6.34e-06	7.05e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ENO2—hematologic cancer	6.27e-06	6.98e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.25e-06	6.95e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ENO2—hematologic cancer	6.22e-06	6.92e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.18e-06	6.87e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—MTHFR—hematologic cancer	6.11e-06	6.79e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.1e-06	6.78e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.09e-06	6.77e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.08e-06	6.76e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.08e-06	6.76e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTP1—hematologic cancer	6.07e-06	6.75e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—IDH2—hematologic cancer	6.04e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HMMR—hematologic cancer	6.04e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.03e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SDC1—hematologic cancer	5.95e-06	6.61e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTP1—hematologic cancer	5.94e-06	6.61e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.94e-06	6.61e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.93e-06	6.59e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SDC1—hematologic cancer	5.9e-06	6.56e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.83e-06	6.49e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ABCB1—hematologic cancer	5.75e-06	6.39e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NUP98—hematologic cancer	5.74e-06	6.38e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.67e-06	6.31e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.63e-06	6.26e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ABCB1—hematologic cancer	5.63e-06	6.26e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTM1—hematologic cancer	5.58e-06	6.2e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NCOR1—hematologic cancer	5.58e-06	6.2e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.57e-06	6.2e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.57e-06	6.2e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.56e-06	6.18e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NUP214—hematologic cancer	5.53e-06	6.15e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CA9—hematologic cancer	5.52e-06	6.14e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ACP5—hematologic cancer	5.52e-06	6.14e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CD44—hematologic cancer	5.5e-06	6.11e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NQO1—hematologic cancer	5.5e-06	6.11e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.48e-06	6.09e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTM1—hematologic cancer	5.46e-06	6.07e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NCOR1—hematologic cancer	5.46e-06	6.07e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.45e-06	6.06e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTR—hematologic cancer	5.42e-06	6.03e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.42e-06	6.03e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.38e-06	5.99e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.32e-06	5.91e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ENO2—hematologic cancer	5.32e-06	5.91e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYCS—hematologic cancer	5.2e-06	5.79e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—IDH1—hematologic cancer	5.19e-06	5.77e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.17e-06	5.75e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.16e-06	5.73e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CG—hematologic cancer	5.13e-06	5.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TXN—hematologic cancer	5.13e-06	5.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.13e-06	5.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.13e-06	5.71e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.08e-06	5.64e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CD44—hematologic cancer	5.06e-06	5.62e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NQO1—hematologic cancer	5.06e-06	5.62e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SDC1—hematologic cancer	5.04e-06	5.6e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.02e-06	5.58e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NQO1—hematologic cancer	5.01e-06	5.58e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CD44—hematologic cancer	5.01e-06	5.58e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—MTHFR—hematologic cancer	4.93e-06	5.48e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.91e-06	5.46e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—MTHFR—hematologic cancer	4.83e-06	5.37e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.82e-06	5.36e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.81e-06	5.35e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYCS—hematologic cancer	4.79e-06	5.32e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CREBBP—hematologic cancer	4.76e-06	5.29e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.76e-06	5.29e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.75e-06	5.28e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYCS—hematologic cancer	4.74e-06	5.28e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.71e-06	5.24e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.69e-06	5.22e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.69e-06	5.22e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.65e-06	5.17e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.59e-06	5.1e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.57e-06	5.09e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.55e-06	5.05e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CD—hematologic cancer	4.51e-06	5.02e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALB—hematologic cancer	4.45e-06	4.95e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.44e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NUP98—hematologic cancer	4.43e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.34e-06	4.83e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.3e-06	4.78e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.3e-06	4.78e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CD44—hematologic cancer	4.28e-06	4.76e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NQO1—hematologic cancer	4.28e-06	4.76e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NUP214—hematologic cancer	4.27e-06	4.75e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3R1—hematologic cancer	4.26e-06	4.74e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.24e-06	4.72e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.22e-06	4.69e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.21e-06	4.69e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.21e-06	4.69e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.2e-06	4.66e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.18e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTR—hematologic cancer	4.18e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.18e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CG—hematologic cancer	4.14e-06	4.6e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ENO2—hematologic cancer	4.1e-06	4.56e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CG—hematologic cancer	4.06e-06	4.51e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYCS—hematologic cancer	4.05e-06	4.51e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.05e-06	4.5e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.03e-06	4.48e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.99e-06	4.44e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.98e-06	4.42e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.96e-06	4.4e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CB—hematologic cancer	3.93e-06	4.37e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SDC1—hematologic cancer	3.89e-06	4.32e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.88e-06	4.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.88e-06	4.31e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.84e-06	4.27e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.84e-06	4.27e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CREBBP—hematologic cancer	3.84e-06	4.27e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.76e-06	4.18e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.72e-06	4.14e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CD—hematologic cancer	3.64e-06	4.05e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.63e-06	4.03e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALB—hematologic cancer	3.59e-06	4e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.57e-06	3.97e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.57e-06	3.96e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALB—hematologic cancer	3.52e-06	3.91e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.46e-06	3.84e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.44e-06	3.82e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.43e-06	3.81e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—hematologic cancer	3.4e-06	3.78e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.4e-06	3.78e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.38e-06	3.76e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.37e-06	3.74e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NQO1—hematologic cancer	3.31e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CD44—hematologic cancer	3.31e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—EP300—hematologic cancer	3.24e-06	3.6e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CB—hematologic cancer	3.17e-06	3.53e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.13e-06	3.48e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYCS—hematologic cancer	3.13e-06	3.48e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.11e-06	3.46e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.11e-06	3.46e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.99e-06	3.33e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.9e-06	3.23e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.9e-06	3.23e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.88e-06	3.2e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.85e-06	3.17e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.76e-06	3.07e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.75e-06	3.06e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—hematologic cancer	2.74e-06	3.05e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALB—hematologic cancer	2.72e-06	3.02e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—hematologic cancer	2.69e-06	2.99e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.67e-06	2.97e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.65e-06	2.94e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—EP300—hematologic cancer	2.62e-06	2.91e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.61e-06	2.9e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.6e-06	2.89e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—EP300—hematologic cancer	2.56e-06	2.85e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.56e-06	2.84e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.53e-06	2.82e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.53e-06	2.82e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.53e-06	2.81e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.51e-06	2.79e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALB—hematologic cancer	2.5e-06	2.78e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALB—hematologic cancer	2.48e-06	2.75e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.44e-06	2.71e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.4e-06	2.67e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—hematologic cancer	2.4e-06	2.67e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.39e-06	2.66e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.37e-06	2.63e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.26e-06	2.51e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.24e-06	2.49e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.21e-06	2.45e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.19e-06	2.43e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.14e-06	2.38e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALB—hematologic cancer	2.12e-06	2.35e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—hematologic cancer	2.07e-06	2.3e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.02e-06	2.25e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—EP300—hematologic cancer	1.98e-06	2.2e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—hematologic cancer	1.96e-06	2.18e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.93e-06	2.15e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—hematologic cancer	1.91e-06	2.12e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.89e-06	2.11e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—hematologic cancer	1.89e-06	2.1e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.88e-06	2.09e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.87e-06	2.08e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—EP300—hematologic cancer	1.82e-06	2.02e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—EP300—hematologic cancer	1.8e-06	2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.74e-06	1.94e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.65e-06	1.84e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALB—hematologic cancer	1.63e-06	1.82e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—hematologic cancer	1.61e-06	1.8e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—hematologic cancer	1.58e-06	1.76e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.56e-06	1.74e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—hematologic cancer	1.55e-06	1.72e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—EP300—hematologic cancer	1.54e-06	1.71e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.46e-06	1.63e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.44e-06	1.6e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.34e-06	1.49e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.33e-06	1.48e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—hematologic cancer	1.25e-06	1.39e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—hematologic cancer	1.19e-06	1.33e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—EP300—hematologic cancer	1.19e-06	1.32e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.14e-06	1.27e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—hematologic cancer	1.1e-06	1.22e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—hematologic cancer	1.09e-06	1.21e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—hematologic cancer	9.3e-07	1.03e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.79e-07	9.77e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—hematologic cancer	7.18e-07	7.98e-06	CbGpPWpGaD
